 |
市場調查報告書
商品編碼
1524280
重建皮膚模型市場 - 類型（重建人類表皮、重建人類皮膚）、應用（皮膚刺激、腐蝕、致敏、活體組織切片、放射性過敏吸附劑和色素沉著測試）、最終用戶、全球預測（2024 - 2032）Reconstructed Skin Models Market - Type (Reconstructed Human Epidermis, Reconstructed Human Skin), Application (Skin Irritation, Corrosion, Sensitization, Biopsy, Radioallergosorbent, & Pigmentation Test), End User, Global Forecast (2024 - 2032) |
||||||
在個人化醫療需求不斷成長和技術快速進步的推動下，2024年至2032年全球重建皮膚模型市場規模的複合年成長率將達到14.6%。隨著醫療保健向個人化治療過渡，重建皮膚模型為安全性和功效測試提供了量身定做的方法，同時滿足了精準醫療的需求。
此外，組織工程和生物技術的不斷進步正在增強這些模型的精確度和可靠性，使它們對於製藥、化妝品和生物技術領域追求日益預測和道德的測試方法不可或缺。例如，2023 年 7 月，歐萊雅與加州大學柏克萊分校貝克實驗室合作，為精選新創公司提供其 3D 重建皮膚模型的存取權限。此次合作為創新公司提供了免費使用歐萊雅先進的非動物測試解決方案以進行安全性和功效測試的機會。
重建皮膚模型市場根據類型、應用、最終用戶和地區進行細分。
按類型分類，到 2032 年，重建人體皮膚細分市場將佔據相當大的行業佔有率，因為它與天然人體皮膚非常相似，可以為安全性和功效測試提供高度準確和可靠的結果。組織工程方法的進步促進了複雜重建的人體皮膚模型的創建，這些模型密切複製了天然皮膚的複雜結構和功能。
根據應用情況，由於人們對化學暴露的不利影響的認知不斷提高以及對準確和道德測試方法的需求，到 2032 年，皮膚致敏測試領域的重建皮膚模型行業將出現顯著成長。重建的皮膚模型為評估皮膚致敏潛力提供了可靠的平台，無需進行動物測試。隨著監管壓力提倡替代測試方法和行業優先考慮安全性，對採用重建皮膚模型的皮膚過敏測試的需求將會增加。
由於先進的醫療基礎設施、廣泛的 RampD 活動和嚴格的監管框架，北美重建皮膚模型產業規模將在 2024 年至 2032 年呈現顯著的複合年成長率。此外，主要市場參與者的存在正在增加對生物技術和製藥行業的投資。隨著對道德測試方法和安全法規的日益重視，北美將脫穎而出，成為市場成長的重要貢獻者。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 擴大採用動物測試的替代測試程序
- 皮膚病盛行率增加
- 日益關注精準化妝品
- 不斷增加對先進體外模型開發的投資
- 產業陷阱與挑戰
- 與不同批次的再現性相關的問題
- 存在嚴格的法規核准流程
- 成長動力
- 成長潛力分析
- 監管環境
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司市佔率分析
- 公司矩陣分析
- 競爭定位矩陣
- 戰略儀表板
第 5 章：市場估計與預測：按類型，2021 - 2032
- 主要趨勢
- 重建人類表皮
- 重建人體皮膚
第 6 章：市場估計與預測：按應用分類，2021 - 2032
- 主要趨勢
- 皮膚刺激測試
- 皮膚腐蝕測試
- 皮膚致敏試驗
- 皮膚切片
- 放射性過敏吸附劑測試
- 皮膚色素沉澱測試
- 其他應用
第 7 章：市場估計與預測：按最終用途，2021 - 2032 年
- 主要趨勢
- 化妝品和藥妝公司
- 化工企業
- 其他最終用戶
第 8 章：市場估計與預測：按地區，2021 - 2032
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
- 中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
第 9 章：公司簡介
- AIVITA Biomedical, Inc.
- BICO - THE BIO CONVERGENCE COMPANY
- CELLnTEC
- EPISKIN
- Henkel AG & Co. KGaA
- Japan Tissue Engineering Co., Ltd.
- Mallinckrodt plc
- STRATICELL
- WEPREDIC Group (Biopredic International)
- ZenBio, Inc.
Global Reconstructed Skin Models Market size will record 14.6% CAGR from 2024 to 2032, driven by the increasing demand for personalized medicine and rapid advancements in technology. As healthcare transitions towards individualized treatments, reconstructed skin models offer a tailored approach for safety and efficacy testing while aligning with the need for precision medicine.
Moreover, the ongoing advancements in tissue engineering and biotechnology are bolstering the precision and dependability of these models, making them indispensable for the pharmaceutical, cosmetic, and biotechnology sectors in pursuit of the increasingly predictive and ethical testing methodologies. For instance, in July 2023, LOreal partnered with UC Berkeley's Baker Labs for offering select start-ups access to its 3D reconstructed skin models. This collaboration provided innovative companies with free access to LOreals advanced non-animal testing solutions for safety and efficacy testing.
The reconstructed skin models market is segmented on the basis of type, application, end-user, and region.
By type, the reconstructed human skin segment will capture considerable industry share by 2032, owing to its close resemblance to natural human skin for providing highly accurate and reliable results for safety and efficacy testing. The progress in tissue engineering methodologies has facilitated the creation of intricately reconstructed human skin models that closely replicate the intricate structure and functions of natural skin.
Based on application, the reconstructed skin models industry from the skin sensitization test segment will witness significant growth by 2032 due to rising awareness regarding the adverse effects of chemical exposure and the need for accurate and ethical testing methods. Reconstructed skin models offer a reliable platform for assessing skin sensitization potential without the need for animal testing. With regulatory pressures advocating alternative testing methods and industries prioritizing safety, the demand for skin sensitization tests employing reconstructed skin models will rise.
North America reconstructed skin models industry size will demonstrate a remarkable CAGR from 2024 to 2032, attributed to the advanced healthcare infrastructure, extensive R&D activities, and stringent regulatory frameworks. Additionally, the presence of key market players is increasing the investments in biotechnology and pharmaceutical sectors. With the growing emphasis on ethical testing methods and safety regulations, North America will stand out as a significant contributor to the market growth.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising adoption of alternative testing procedures to animal testing
- 3.2.1.2 Increasing prevalence of skin disorders
- 3.2.1.3 Growing focus on precision cosmetic products
- 3.2.1.4 Growing investments in the development of advanced in-vitro models
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Concerns related to reproducibility across different batches
- 3.2.2.2 Presence of stringent regulatory approval process
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Reconstructed human epidermis
- 5.3 Reconstructed human skin
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Skin irritation test
- 6.3 Skin corrosion test
- 6.4 Skin sensitization test
- 6.5 Skin biopsy
- 6.6 Radioallergosorbent test
- 6.7 Skin pigmentation test
- 6.8 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Cosmetics and cosmeceutical companies
- 7.3 Chemical companies
- 7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 AIVITA Biomedical, Inc.
- 9.2 BICO - THE BIO CONVERGENCE COMPANY
- 9.3 CELLnTEC
- 9.4 EPISKIN
- 9.5 Henkel AG & Co. KGaA
- 9.6 Japan Tissue Engineering Co., Ltd.
- 9.7 Mallinckrodt plc
- 9.8 STRATICELL
- 9.9 WEPREDIC Group (Biopredic International)
- 9.10 ZenBio, Inc.
